Abraxane nab-paclitaxel regulatory update

Health Canada approved Celgene's Abraxane nab-paclitaxel for the first-line treatment of metastatic pancreatic cancer in combination with gemcitabine. The albumin stabilized nanoparticle formulation of paclitaxel is already marketed in the country to treat metastatic breast cancer. ...